Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021
The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 million by 2021 from USD 207.9 million in 2016, at a CAGR of 6.9% between 2016 and 2021. North America is expected to hold the largest share of the varicose vein treatment market in 2016. The varicose vein treatment market is broadly segmented into mode of treatment and products. By products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. In 2016, the radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment.
Geographically, the report covers two major geographies, namely, North America and Europe. In this report, the North American varicose vein treatment market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the varicose vein treatment market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.
Market growth is majorly driven by the shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, huge burden of varicose vein cases in North America and Europe, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.
As of 2015, the varicose vein treatment market was dominated by Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); and biolitec AG (Austria) which together held a share of over 85% of the varicose vein treatment market. New product launches, strategic acquisitions, and agreements are the major strategies adopted by most market players to achieve growth in the varicose vein treatment market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis —market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the varicose vein treatment market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
Geographically, the report covers two major geographies, namely, North America and Europe. In this report, the North American varicose vein treatment market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the varicose vein treatment market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.
Market growth is majorly driven by the shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, huge burden of varicose vein cases in North America and Europe, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.
As of 2015, the varicose vein treatment market was dominated by Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); and biolitec AG (Austria) which together held a share of over 85% of the varicose vein treatment market. New product launches, strategic acquisitions, and agreements are the major strategies adopted by most market players to achieve growth in the varicose vein treatment market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis —market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the varicose vein treatment market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on varicose vein treatment products offered by the top 5 players in the varicose vein treatment market. The report analyzes the varicose vein treatment market by mode of treatment and products
- Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements, and new product launches in the varicose vein treatment market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various varicose vein treatment devices across North America and Europe
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the varicose vein treatment market
1 RESEARCH METHODOLOGY
2 VARICOSE VEIN TREATMENT MARKET IN NORTH AMERICA AND EUROPE SNAPSHOT
3.2 INTRODUCTION
3.1 MARKET SEGMENTATION
4.1 OVERVIEW
4.2 KEY MARKET DRIVERS
4.3 KEY MARKET RESTRAINTS
4.4 KEY MARKET OPPORTUNITIES
4.5 KEY MARKET CHALLENGES
4.6 INTRODUCTION
5.1 ENDOVENOUS ABLATION
5.2 INJECTION SCLEROTHERAPY
5.3 SURGICAL LIGATION/STRIPPING
5.4 INTRODUCTION
6.1 ABLATION DEVICES
6.2 EXECUTIVE SUMMARY
6.3 VENOUS CLOSURE PRODUCTS SURGICAL PRODUCTS
6.4 RADIOFREQUENCY ABLATION DEVICES
6.2.1 LASER ABLATION DEVICES
6.2.2 VARICOSE VEIN TREATMENT MARKET, BY REGION
7 INTRODUCTION
7.1 NORTH AMERICA
7.2 U.S.
7.2.1 CANADA
7.2.2 EUROPE
7.3 GERMANY
7.3.1 FRANCE
7.3.2 U.K.
7.3.3 ITALY
7.3.4 SPAIN
7.3.5 REST OF EUROPE (RoE)
7.3.6 NEW PRODUCT LAUNCHES
8.4.1 COMPETITIVE SCENARIO
8.3 RECENT DEVELOPMENTS
8.4 ACQUISITIONS
8.4.2 AGREEMENTS
8.4.3 OTHER DEVELOPMENTS
8.4.4 INTRODUCTION
8.1 MARKET SHARE ANALYSIS
8.2 INTRODUCTION
9.1 GEOGRAPHIC BENCHMARKING
9.1.1 MEDTRONIC, PLC (IRELAND)
9.2 COMPANY OVERVIEW
9.2.1 MnM VIEW
9.2.2 MEDTRONIC PLC –COMPANY SNAPSHOT
9.2.3 PRODUCT PORTFOLIO
9.2.4 RECENT DEVELOPMENTS (2013-2016)
9.2.5 COMPETITIVE LANDSCAPE
9.3 COMPANY OVERVIEW
9.3.1 MnM VIEW
9.3.2 ANGIODYNAMICS, INC. –COMPANY SNAPSHOT
9.3.3 PRODUCT PORTFOLIO
9.3.4 RECENT DEVELOPMENTS (2013-2016)
9.3.5 BIOLITEC AG (AUSTRIA)
9.4 COMPANY OVERVIEW
9.4.1 MnM VIEW
9.4.2 PRODUCT PORTFOLIO
9.4.3 RECENT DEVELOPMENTS (2013-2016)
9.4.4 SYNERON MEDICAL LTD. (ISRAEL)
9.5 COMPANY OVERVIEW
9.5.1 MnM VIEW
9.5.2 PRODUCT PORTFOLIO
9.5.4 RECENT DEVELOPMENTS (2013-2016)
9.5.5 SYNERON MEDICAL LTD. –COMPANY SNAPSHOT
9.5.3 LUMENIS LTD. (ISRAEL)
9.6 COMPANY OVERVIEW
9.6.1 MnM VIEW
9.6.2 PRODUCT PORTFOLIO
9.6.3 RECENT DEVELOPMENTS (2013-2016)
9.6.4 DISCUSSION GUIDE
10.1 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
10.2 AVAILABLE CUSTOMIZATIONS
10.4 RELATED REPORTS
2 VARICOSE VEIN TREATMENT MARKET IN NORTH AMERICA AND EUROPE SNAPSHOT
3.2 INTRODUCTION
3.1 MARKET SEGMENTATION
4.1 OVERVIEW
4.2 KEY MARKET DRIVERS
4.3 KEY MARKET RESTRAINTS
4.4 KEY MARKET OPPORTUNITIES
4.5 KEY MARKET CHALLENGES
4.6 INTRODUCTION
5.1 ENDOVENOUS ABLATION
5.2 INJECTION SCLEROTHERAPY
5.3 SURGICAL LIGATION/STRIPPING
5.4 INTRODUCTION
6.1 ABLATION DEVICES
6.2 EXECUTIVE SUMMARY
6.3 VENOUS CLOSURE PRODUCTS SURGICAL PRODUCTS
6.4 RADIOFREQUENCY ABLATION DEVICES
6.2.1 LASER ABLATION DEVICES
6.2.2 VARICOSE VEIN TREATMENT MARKET, BY REGION
7 INTRODUCTION
7.1 NORTH AMERICA
7.2 U.S.
7.2.1 CANADA
7.2.2 EUROPE
7.3 GERMANY
7.3.1 FRANCE
7.3.2 U.K.
7.3.3 ITALY
7.3.4 SPAIN
7.3.5 REST OF EUROPE (RoE)
7.3.6 NEW PRODUCT LAUNCHES
8.4.1 COMPETITIVE SCENARIO
8.3 RECENT DEVELOPMENTS
8.4 ACQUISITIONS
8.4.2 AGREEMENTS
8.4.3 OTHER DEVELOPMENTS
8.4.4 INTRODUCTION
8.1 MARKET SHARE ANALYSIS
8.2 INTRODUCTION
9.1 GEOGRAPHIC BENCHMARKING
9.1.1 MEDTRONIC, PLC (IRELAND)
9.2 COMPANY OVERVIEW
9.2.1 MnM VIEW
9.2.2 MEDTRONIC PLC –COMPANY SNAPSHOT
9.2.3 PRODUCT PORTFOLIO
9.2.4 RECENT DEVELOPMENTS (2013-2016)
9.2.5 COMPETITIVE LANDSCAPE
9.3 COMPANY OVERVIEW
9.3.1 MnM VIEW
9.3.2 ANGIODYNAMICS, INC. –COMPANY SNAPSHOT
9.3.3 PRODUCT PORTFOLIO
9.3.4 RECENT DEVELOPMENTS (2013-2016)
9.3.5 BIOLITEC AG (AUSTRIA)
9.4 COMPANY OVERVIEW
9.4.1 MnM VIEW
9.4.2 PRODUCT PORTFOLIO
9.4.3 RECENT DEVELOPMENTS (2013-2016)
9.4.4 SYNERON MEDICAL LTD. (ISRAEL)
9.5 COMPANY OVERVIEW
9.5.1 MnM VIEW
9.5.2 PRODUCT PORTFOLIO
9.5.4 RECENT DEVELOPMENTS (2013-2016)
9.5.5 SYNERON MEDICAL LTD. –COMPANY SNAPSHOT
9.5.3 LUMENIS LTD. (ISRAEL)
9.6 COMPANY OVERVIEW
9.6.1 MnM VIEW
9.6.2 PRODUCT PORTFOLIO
9.6.3 RECENT DEVELOPMENTS (2013-2016)
9.6.4 DISCUSSION GUIDE
10.1 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
10.2 AVAILABLE CUSTOMIZATIONS
10.4 RELATED REPORTS
LIST OF TABLES
Table - 1 PREVALENCE OF VARICOSE VEINS IN THE EUROPEAN REGION
Table – 2 PREVALENCE OF PRIMARY VARICOSE VEINS IN EUROPEAN REGION (2013) (THOUSAND)
Table – 3 REIMBURSEMENT SCENARIO FOR VARICOSE VEIN TREATMENTS IN EUROPE, BY COUNTRY
Table – 4 VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 5 VARICOSE VEIN TREATMENT MODES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 6 VARICOSE VEIN TREATMENT MODES MARKET SIZE (USD MILLION) AND MARKET SHARE (%), BY COUNTRY, 2016
Table – 7 NORTH AMERICA: VARICOSE VEIN TREATMENT MODES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 8 EUROPE: VARICOSE VEIN TREATMENT MODES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 9 ENDOVENOUS ABLATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 10 NORTH AMERICA: ENDOVENOUS ABLATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 11 EUROPE: ENDOVENOUS ABLATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 12 INJECTION SCLEROTHERAPY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 13 NORTH AMERICA: INJECTION SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 14 EUROPE: INJECTION SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 15 SURGICAL LIGATION/STRIPPING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 16 NORTH AMERICA: SURGICAL LIGATION/STRIPPING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 17 EUROPE: SURGICAL LIGATION/STRIPPING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 18 VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 19 VARICOSE VEIN TREATMENT PRODUCT MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 20 NORTH AMERICA: VARICOSE VEIN TREATMENT PRODUCT MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 21 EUROPE: VARICOSE VEIN TREATMENT PRODUCT MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 22 VARICOSE VEIN TREATMENT ABLATION DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table – 23 ABLATION DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 24 NORTH AMERICA: ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 25 EUROPE: ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 26 RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 27 NORTH AMERICA: RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY COUNTRY 2014–2021 (USD MILLION)
Table – 28 LASER ABLATION DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 29 NORTH AMERICAN VENOUS CLOSURE PRODUCTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 30 NORTH AMERICA: LASER ABLATION DEVICES MARKET SIZE, BY COUNTRY 2014–2021 (USD MILLION)
Table – 31 EUROPE: LASER ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 32 VENOUS CLOSURE PRODUCTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 33 NORTH AMERICA: VENOUS CLOSURE PRODUCTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 34 EUROPE: VENOUS CLOSURE PRODUCTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 35 SURGICAL PRODUCTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 36 NORTH AMERICA: SURGICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 37 EUROPE: SURGICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 38 VARICOSE VEIN TREATMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table – 39 VARICOSE VEIN TREATMENT MARKET SIZE, BY COUNTRY 2014-2021 (USD MILLION)
Table – 40 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SIZE, BY COUNTRY AND TREATMENT MODE, 2016 (USD MILLION)
Table – 41 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table – 42 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SIZE, BY MODE OF TREATMENT, 2014-2021 (USD MILLION)
Table – 43 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table – 44 U.S.: VARICOSE VEIN TREATMENT MARKET SIZE, BY MODE OF TREATMENT, 2014-2021 (USD MILLION)
Table – 45 U.S.: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table – 46 CANADA: VARICOSE VEIN TREATMENT MARKET SIZE, BY MODE OF TREATMENT, 2014-2021 (USD MILLION)
Table – 47 CANADA: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table – 48 EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY COUNTRY AND TREATMENT MODE, 2016 (USD MILLION)
Table – 49 EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table – 50 EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY MODE OF TREATMENT, 2014-2021 (USD MILLION)
Table – 51 EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table – 52 GERMANY: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 53 GERMANY: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 54 FRANCE: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 55 FRANCE: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 56 U.K.: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 57 U.K.: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 58 ITALY: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 59 ITALY: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 60 SPAIN: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 61 SPAIN: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 62 REST OF EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 63 REST OF EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 64 NEW PRODUCT LAUNCHES (2013–2016) (CNTD…)
Table – 65 ACQUISITIONS (2013-2016)
Table – 66 AGREEMENTS (2013-2016)
Table – 67 OTHER DEVELOPMENTS (2013-2016)
Table - 1 PREVALENCE OF VARICOSE VEINS IN THE EUROPEAN REGION
Table – 2 PREVALENCE OF PRIMARY VARICOSE VEINS IN EUROPEAN REGION (2013) (THOUSAND)
Table – 3 REIMBURSEMENT SCENARIO FOR VARICOSE VEIN TREATMENTS IN EUROPE, BY COUNTRY
Table – 4 VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 5 VARICOSE VEIN TREATMENT MODES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 6 VARICOSE VEIN TREATMENT MODES MARKET SIZE (USD MILLION) AND MARKET SHARE (%), BY COUNTRY, 2016
Table – 7 NORTH AMERICA: VARICOSE VEIN TREATMENT MODES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 8 EUROPE: VARICOSE VEIN TREATMENT MODES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 9 ENDOVENOUS ABLATION MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 10 NORTH AMERICA: ENDOVENOUS ABLATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 11 EUROPE: ENDOVENOUS ABLATION MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 12 INJECTION SCLEROTHERAPY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 13 NORTH AMERICA: INJECTION SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 14 EUROPE: INJECTION SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 15 SURGICAL LIGATION/STRIPPING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 16 NORTH AMERICA: SURGICAL LIGATION/STRIPPING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 17 EUROPE: SURGICAL LIGATION/STRIPPING MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 18 VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 19 VARICOSE VEIN TREATMENT PRODUCT MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 20 NORTH AMERICA: VARICOSE VEIN TREATMENT PRODUCT MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 21 EUROPE: VARICOSE VEIN TREATMENT PRODUCT MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 22 VARICOSE VEIN TREATMENT ABLATION DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table – 23 ABLATION DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 24 NORTH AMERICA: ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 25 EUROPE: ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 26 RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 27 NORTH AMERICA: RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY COUNTRY 2014–2021 (USD MILLION)
Table – 28 LASER ABLATION DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 29 NORTH AMERICAN VENOUS CLOSURE PRODUCTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 30 NORTH AMERICA: LASER ABLATION DEVICES MARKET SIZE, BY COUNTRY 2014–2021 (USD MILLION)
Table – 31 EUROPE: LASER ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 32 VENOUS CLOSURE PRODUCTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 33 NORTH AMERICA: VENOUS CLOSURE PRODUCTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 34 EUROPE: VENOUS CLOSURE PRODUCTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 35 SURGICAL PRODUCTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table – 36 NORTH AMERICA: SURGICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 37 EUROPE: SURGICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table – 38 VARICOSE VEIN TREATMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table – 39 VARICOSE VEIN TREATMENT MARKET SIZE, BY COUNTRY 2014-2021 (USD MILLION)
Table – 40 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SIZE, BY COUNTRY AND TREATMENT MODE, 2016 (USD MILLION)
Table – 41 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table – 42 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SIZE, BY MODE OF TREATMENT, 2014-2021 (USD MILLION)
Table – 43 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table – 44 U.S.: VARICOSE VEIN TREATMENT MARKET SIZE, BY MODE OF TREATMENT, 2014-2021 (USD MILLION)
Table – 45 U.S.: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table – 46 CANADA: VARICOSE VEIN TREATMENT MARKET SIZE, BY MODE OF TREATMENT, 2014-2021 (USD MILLION)
Table – 47 CANADA: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table – 48 EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY COUNTRY AND TREATMENT MODE, 2016 (USD MILLION)
Table – 49 EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
Table – 50 EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY MODE OF TREATMENT, 2014-2021 (USD MILLION)
Table – 51 EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table – 52 GERMANY: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 53 GERMANY: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 54 FRANCE: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 55 FRANCE: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 56 U.K.: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 57 U.K.: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 58 ITALY: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 59 ITALY: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 60 SPAIN: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 61 SPAIN: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 62 REST OF EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY TREATMENT MODE, 2014–2021 (USD MILLION)
Table – 63 REST OF EUROPE: VARICOSE VEIN TREATMENT MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table – 64 NEW PRODUCT LAUNCHES (2013–2016) (CNTD…)
Table – 65 ACQUISITIONS (2013-2016)
Table – 66 AGREEMENTS (2013-2016)
Table – 67 OTHER DEVELOPMENTS (2013-2016)
LIST OF FIGURES
Figure-1 RESEARCH DESIGN
Figure-2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & COUNTRY
Figure-3 NORTH AMERICAN VARICOSE VEIN TREATMENT MARKET, BY COUNTRY: MARKET SHARE (2016) AND CAGR (2016–2021)
Figure-4 EUROPEAN VARICOSE VEIN TREATMENT MARKET, BY COUNTRY: MARKET SHARE (2016) AND CAGR (2016–2021)
Figure-5 HEALTHCARE EXPENDITURES AS PERCENTAGE OF GDP IN MAJOR EUROPEAN COUNTRIES
Figure-6 KEY VARICOSE VEIN TREATMENT MARKETS: CHANGING PROPORTION OF GERIATRIC INDIVIDUALS (AGED 65 YEARS AND ABOVE) IN TOTAL POPULATION (2020 VS. 2030)
Figure-7 VARICOSE VEIN TREATMENT MARKET SHARE, BY PRODUCT (2016–2021) (USD MILLION)
Figure-8 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET, BY MODE OF TREATMENT, 2016 (%)
Figure-9 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SHARE, BY COUNTRY(2016 VS. 2021)
Figure-10 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SHARE, BY MODE OF TREATMENT, 2016
Figure-11 EUROPE: VARICOSE VEIN TREATMENT MARKET, BY MODE OF TREATMENT, 2016 (USD MILLION)
Figure-12 EUROPE: VARICOSE VEIN TREATMENT MARKET SHARE, BY COUNTRY (2016 VS. 2021)
Figure-13 EU-5: VARICOSE VEIN TREATMENT MARKET SHARE, BY MODE OF TREATMENT, 2016
Figure-14 LEADING MARKET PLAYERS ADOPTED PRODUCT DEVELOPMENT AND COMMERCIALIZATION AS KEY GROWTH STRATEGIES DURING 2012-2015
Figure-15 VARICOSE VEIN TREATMENT MARKET SHARE, BY KEY PLAYER (2015)
Figure-16 PRODUCT DEVELOPMENT, THE MOST WIDELY ADOPTED GROWTH STRATEGY DURING 2013-2016
Figure-17 GEOGRAPHIC BENCHMARKING
Figure-18 MARKETSANDMARKETS KNOWLEDGE STORE SNAPSHOT
Figure-19 MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE INDUSTRY SNAPSHOT
Figure-1 RESEARCH DESIGN
Figure-2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, & COUNTRY
Figure-3 NORTH AMERICAN VARICOSE VEIN TREATMENT MARKET, BY COUNTRY: MARKET SHARE (2016) AND CAGR (2016–2021)
Figure-4 EUROPEAN VARICOSE VEIN TREATMENT MARKET, BY COUNTRY: MARKET SHARE (2016) AND CAGR (2016–2021)
Figure-5 HEALTHCARE EXPENDITURES AS PERCENTAGE OF GDP IN MAJOR EUROPEAN COUNTRIES
Figure-6 KEY VARICOSE VEIN TREATMENT MARKETS: CHANGING PROPORTION OF GERIATRIC INDIVIDUALS (AGED 65 YEARS AND ABOVE) IN TOTAL POPULATION (2020 VS. 2030)
Figure-7 VARICOSE VEIN TREATMENT MARKET SHARE, BY PRODUCT (2016–2021) (USD MILLION)
Figure-8 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET, BY MODE OF TREATMENT, 2016 (%)
Figure-9 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SHARE, BY COUNTRY(2016 VS. 2021)
Figure-10 NORTH AMERICA: VARICOSE VEIN TREATMENT MARKET SHARE, BY MODE OF TREATMENT, 2016
Figure-11 EUROPE: VARICOSE VEIN TREATMENT MARKET, BY MODE OF TREATMENT, 2016 (USD MILLION)
Figure-12 EUROPE: VARICOSE VEIN TREATMENT MARKET SHARE, BY COUNTRY (2016 VS. 2021)
Figure-13 EU-5: VARICOSE VEIN TREATMENT MARKET SHARE, BY MODE OF TREATMENT, 2016
Figure-14 LEADING MARKET PLAYERS ADOPTED PRODUCT DEVELOPMENT AND COMMERCIALIZATION AS KEY GROWTH STRATEGIES DURING 2012-2015
Figure-15 VARICOSE VEIN TREATMENT MARKET SHARE, BY KEY PLAYER (2015)
Figure-16 PRODUCT DEVELOPMENT, THE MOST WIDELY ADOPTED GROWTH STRATEGY DURING 2013-2016
Figure-17 GEOGRAPHIC BENCHMARKING
Figure-18 MARKETSANDMARKETS KNOWLEDGE STORE SNAPSHOT
Figure-19 MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE INDUSTRY SNAPSHOT
